Repligen Corporation Profile Avatar - Palmy Investing

Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding com…

Medical - Instruments & Supplies
US, Waltham [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Repligen Corporation can't present it's latest revenue by geo. area

Revenue By Geographic Areas

Repligen Corporation can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

Repligen Corporation can't present revenue by segment

Historical Revenue By Geographic Area

Last 3Y, in mil. USD

Repligen Corporation can't present revenue by geo. area

End of RGEN's Analysis
CIK: 730272 CUSIP: 759916109 ISIN: US7599161095 LEI: - UEI: -
Secondary Listings
RGEN has no secondary listings inside our databases.